AnaBio Technologies

What AnaBio Technologies does

AnaBio Technologies is an Irish microencapsulation company founded in 2011, headquartered in Dublin with manufacturing operations in Carrigtwohill, Co. Cork. The company specializes in protecting sensitive functional ingredients — primarily probiotics (Lactobacillus and Bifidobacteria species), vitamins, minerals, amino acids, oils, and botanical extracts — using its patented EnCaptimus™ protein-based coating technology. This coating shields ingredients from heat (surviving UHT processing up to 143°C for 5 seconds), moisture, and acidic environments, enabling 12-month ambient stability and over 80% probiotic viability through gastrointestinal digestion. Quality verification uses ISO 19344-compliant flow cytometry enumeration (Active Fluorescent Units), providing more accurate counts than traditional CFU methods.

The company operates a B2B model serving food and beverage, nutraceutical, and animal nutrition manufacturers globally, with products distributed across 9 countries in the world's top 10 innovation clusters. Revenue is generated through three streams: direct sales of encapsulated probiotic and bioactive ingredients (sold as powders in vacuum-sealed foil bags and bag-in-box formats), technology licensing arrangements with exclusivity provisions, and collaborative R&D and product development services from concept through commercial production. The Cork manufacturing facility is FSSC 22000 and FDA approved, with encapsulated probiotics holding GRAS status.

Strategic partnerships anchor the go-to-market motion, including a co-development relationship with SIG Combibloc for aseptic probiotic beverages, testing partnerships with Eurofins, and consumer product launches with 96B Coffee Roastery (EnCaptimus Probiotic Coffee) and SISU (Probiotic Kombucha, winner of Ireland's Great Taste Award). AnaBio holds 12+ patent families covering the encapsulation platform and operates without external institutional investors, funding growth through founder-led ownership and operating cash flow.

Name

AnaBio Technologies

Legal name

AnaBio Technologies

Website

https://anabio.ie

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

AnaBio Technologies is an Irish microencapsulation company that uses its patented EnCaptimus™ protein-coating technology to protect probiotics, vitamins, and bioactives from heat and moisture, selling encapsulated ingredients and licensing technology to food, beverage, nutraceutical, and animal nutrition manufacturers globally.

Ownership category

akta.pro rank

Product category

Microencapsulation Ingredients and Technology

NAICS

Food Manufacturing (311)

SIC

Food And Kindred Products (2000), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Culture Carriers & Encapsulation Systems (Cryoprotectants, Microencapsulation, Delivery Matrices) (AFAJAJAK)

akta.pro secondary industries

Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery) (HLAAAFAJ), Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases) (AFAJAJAE), Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation) (AFAJACAL), Probiotics & Digestive Health Supplements (CRADAGAF)

Keywords

• Microencapsulation technology
• Encapsulated probiotics
• Bioactive ingredient protection
• Contract manufacturing ingredients
• Technology licensing encapsulation

Headquarters

HQ city

Dublin

HQ country

Ireland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Encapsulated Ingredient Sales: Sale of off-the-shelf and bespoke encapsulated probiotics and bioactives (vitamins, minerals, amino acids) to food, beverage, nutraceutical, and animal nutrition manufacturers. Ingredients sold in powder form in vacuum-sealed foil bags (2.5kg) or up to 25kg bag-in-box formats.
2. Technology Licensing: Licensing arrangements allowing partners to secure exclusivity and conduct the encapsulation process themselves as volumes grow or for strategic reasons. Supported by 12 patent families forming a robust licensing platform.
3. R&D and Product Development Services: Collaborative product development services from concept stage through commercial production, assisting clients to develop encapsulated products tailored to specific applications and customer needs.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

AnaBio Technologies provides patented protein-based microencapsulation services and contract manufacturing of encapsulated probiotics (Lactobacillus and Bifidobacteria strains) and bioactives (vitamins, minerals, amino acids, oils, botanicals) for food, beverage, nutraceutical, and animal nutrition manufacturers. The technology protects sensitive ingredients from heat, moisture, and stomach acid while enabling controlled release in the gut, with products sold in vacuum-sealed foil bags (2.5kg to 25kg bag-in-box) from an FFSC22000 and FDA-approved Cork facility. The company also licenses its EnCaptimus™ technology to strategic partners with exclusivity arrangements.

Product overview

AnaBio Technologies is a specialist Irish microencapsulation company offering the EnCaptimus™ technology platform as the core of its product portfolio. The platform provides microencapsulation of sensitive functional ingredients including probiotics (Lactobacillus and Bifidobacteria species) and bioactives (vitamins, minerals, amino acids, and other compounds). The technology creates a protective protein-based coating that enables these ingredients to survive high-temperature processing, ambient storage, and stomach acid passage. The product range includes encapsulated probiotic and bioactive ingredients sold to food and beverage manufacturers, along with concept demonstrations showing applications in beverages, chocolate, pasta, and coffee. The company operates an FFSC22000 and FDA-approved manufacturing facility and licenses its technology to partners seeking exclusive access.

Differentiator

Problem solved

Functional benefit

Brands

• EnCaptimus Beverage: Shelf-stable probiotic beverage technology platform enabling live probiotics in ambient storage for up to 12 months.
• EnCaptimus Probiotic Chocolate
• EnCaptimus Probiotic Coffee
• EnCaptimus Pasta

Products and services

• EnCaptimus™ Technology Platform AnaBio's patented microencapsulation technology platform that creates a protective protein-based coating around probiotics and bioactives, protecting them from heat (surviving UHT up to 143°C for 5 seconds), moisture, and stomach acid while enabling targeted release in the gut via protease breakdown of the protein coating. Sold and licensed to food, beverage, nutraceutical, and animal nutrition manufacturers.
• Encapsulated Probiotics Microencapsulated Lactobacillus and Bifidobacteria probiotic strains that survive high-temperature processing and remain viable for 12 months in liquid environments at ambient temperature, with GRAS approval and vegetarian suitability. Sold in vacuum-sealed foil bags (2.5kg) or larger 25kg bag-in-box formats to food, beverage, and nutraceutical manufacturers.
• Encapsulated Bioactives Encapsulated vitamins (B12, C, D3, K, folic acid), minerals (iron, zinc), amino acids, creatine, caffeine, hyaluronic acid, melatonin, curcumin, and omega-3 oils provided with heat/moisture protection, taste masking, controlled release, and improved bioavailability for B2B manufacturers.
• EnCaptimus Beverage Concept Shelf-stable probiotic beverages enabled by encapsulation technology, allowing live probiotics in ambient-stable drinks including sodas, juices, fermented beverages, brewed long drinks, and teas with 12-month ambient stability at 25°C.
• EnCaptimus Chocolate Concept Probiotic chocolate delivering 2 billion CFU of live cultures per 30g serving, using cocoa butter as a superior carrier for probiotic delivery with encapsulation protection.
• EnCaptimus Pasta Concept Probiotic pasta with heat-resistant encapsulated cultures that survive boiling and release in the small intestine to support gut comfort and reduce bloating.
• EnCaptimus Coffee Concept World's first shelf-stable probiotic coffee pod delivering live cultures with over 90% survival rate through coffee machine temperatures and stomach acid, with zero sensory impact on coffee flavour. Launched in partnership with 96B Coffee Roastery.

Quantifiable outcome

• Over 80% probiotic viability retained after simulated gastrointestinal digestion (vs. <20% for non-encapsulated)
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered supportive and core.

• Eurofins Food Testing VietnamsupportiveTechnology or IntegrationTrusted partner testing laboratory providing independent verification of AnaBio's encapsulated products. Eurofins conducts quality and stability testing across their global network.
• SIG CombibloccoreStrategic or Co-development PartnerDemonstration partnership showcasing how AnaBio's encapsulation technology combines with SIG's packaging solutions to create healthy convenient aseptic probiotic beverages in sustainable packaging. Presented at MISTA Symposium.
• 96B Coffee RoasterycoreStrategic or Co-development PartnerProduct development partnership to launch new coffee line featuring EnCaptimus encapsulated probiotics. Partnership supported by Irish Embassy with Irish Minister for Agriculture present at launch event.
• SISUcoreStrategic or Co-development PartnerBeverage partner producing Ginger and Lemongrass Kombucha using AnaBio's encapsulation technology. Product won Ireland's Great Taste Award, validating functional flavor approach.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• AB Biotics: Spanish probiotic ingredient company developing proprietary strains for functional food and dietary supplements. Comparable as a smaller, probiotic-focused ingredient supplier targeting overlapping food and nutraceutical manufacturer customers.

Direct peers

• Lallemand: Canadian-headquartered yeast and bacteria specialist producing probiotic strains for human nutrition, animal feed, and beverages. Highly comparable as a probiotic ingredient supplier targeting food, beverage, and animal nutrition manufacturers.
• BioGaia: Swedish probiotic specialist developing and commercializing Lactobacillus reuteri strains for dietary supplements, infant formula, and functional food. Comparable as a probiotic-focused company targeting nutraceutical and functional food manufacturers.
• Kerry Group: Irish-headquartered global taste and nutrition company with a major probiotics and functional ingredients portfolio serving food and beverage manufacturers. Directly comparable as an Irish-listed food ingredients peer with overlapping encapsulation and probiotic capabilities.
• Chr. Hansen: Global bioscience company producing probiotic cultures and food enzymes for dairy, beverage, and supplement manufacturers. Highly comparable as a probiotic strain and ingredient supplier serving overlapping food/beverage manufacturer customers.

Broad incumbents

• Tate & Lyle: Global food and beverage ingredient supplier with capabilities in stabilization, encapsulation, and functional ingredients. Comparable as a broad incumbent offering overlapping encapsulation and food ingredient solutions to CPG manufacturers.
• International Flavors & Fragrances (IFF): Global ingredients major formed via the DuPont Nutrition & Biosciences merger, with a Health & Biosciences division spanning cultures, probiotics, and encapsulation. Comparable as a broad incumbent offering overlapping encapsulation and probiotic solutions to food/beverage customers.
• ADM: Global agricultural processor and major food ingredient supplier with extensive probiotics, flavors, and functional ingredient capabilities serving CPG manufacturers worldwide. Comparable as a broad incumbent with overlapping encapsulation-adjacent capabilities and food/beverage customer base.
• Lonza (Capsugel): Global CDMO with the Capsugel encapsulation portfolio offering a wide range of capsule and particle technologies for pharma and nutrition. Comparable as a large-scale encapsulation technology provider targeting nutraceutical and functional food manufacturers.

Regional players

• Glanbia: Irish-headquartered global nutrition company with performance nutrition, ingredients, and dairy consumer products divisions. Comparable as an Irish-domiciled nutrition and functional ingredients peer with overlapping customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/anabio-technologies-ltd-
• Xx.com/AnaBio_Tech

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AnaBio Technologies